Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Vaccine Therapy in Patients With Stages IIIB/IV Non-Small Cell Lung Cancer Who Have Finished First-Line Chemotherapy
Phase I/II Clinical Trial of Immunotherapy With an Allogeneic B7.1/HLA-A1 Transfected Tumor Cell Vaccine in Patients With Stages IIIB/IV Non-Small Cell Lung Cancer That Have Completed First Line Chemotherapy
Status: Enrolling
Updated:  9/14/2017
Memorial Regional Hospital
mi
from
Hollywood, FL
Vaccine Therapy in Patients With Stages IIIB/IV Non-Small Cell Lung Cancer Who Have Finished First-Line Chemotherapy
Phase I/II Clinical Trial of Immunotherapy With an Allogeneic B7.1/HLA-A1 Transfected Tumor Cell Vaccine in Patients With Stages IIIB/IV Non-Small Cell Lung Cancer That Have Completed First Line Chemotherapy
Status: Enrolling
Updated: 9/14/2017
Memorial Regional Hospital
mi
from
Hollywood, FL
Click here to add this to my saved trials
Vaccine Therapy in Patients With Stages IIIB/IV Non-Small Cell Lung Cancer Who Have Finished First-Line Chemotherapy
Phase I/II Clinical Trial of Immunotherapy With an Allogeneic B7.1/HLA-A1 Transfected Tumor Cell Vaccine in Patients With Stages IIIB/IV Non-Small Cell Lung Cancer That Have Completed First Line Chemotherapy
Status: Enrolling
Updated:  9/14/2017
University of Miami, Sylvester Comprehensive Cancer Center
mi
from
Miami, FL
Vaccine Therapy in Patients With Stages IIIB/IV Non-Small Cell Lung Cancer Who Have Finished First-Line Chemotherapy
Phase I/II Clinical Trial of Immunotherapy With an Allogeneic B7.1/HLA-A1 Transfected Tumor Cell Vaccine in Patients With Stages IIIB/IV Non-Small Cell Lung Cancer That Have Completed First Line Chemotherapy
Status: Enrolling
Updated: 9/14/2017
University of Miami, Sylvester Comprehensive Cancer Center
mi
from
Miami, FL
Click here to add this to my saved trials
The Effect of Sodium Thiosulfate Eardrops on Hearing Loss in Patients Who Receive Cisplatin Therapy
A Pilot, Randomized, Self-controlled Study of the Effects of Intratympanic Sodium Thiosulfate on the Degree of Hearing Loss in Patients Receiving Cisplatin Therapy
Status: Enrolling
Updated:  9/15/2017
Thomas Jefferson University
mi
from
Philadelphia, PA
The Effect of Sodium Thiosulfate Eardrops on Hearing Loss in Patients Who Receive Cisplatin Therapy
A Pilot, Randomized, Self-controlled Study of the Effects of Intratympanic Sodium Thiosulfate on the Degree of Hearing Loss in Patients Receiving Cisplatin Therapy
Status: Enrolling
Updated: 9/15/2017
Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung Cancer
A Phase II Randomized Trial of Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung Cancer Who Have Received First-line Platinum-based Chemotherapy With or Without Bevacizumab
Status: Enrolling
Updated:  9/18/2017
University of Pittsburgh Cancer Institute
mi
from
Pittsburgh, PA
Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung Cancer
A Phase II Randomized Trial of Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung Cancer Who Have Received First-line Platinum-based Chemotherapy With or Without Bevacizumab
Status: Enrolling
Updated: 9/18/2017
University of Pittsburgh Cancer Institute
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Patency of a Prototype Large Plastic Biliary Stent in the Palliation of Malignant Distal Biliary Strictures.
Prospective Evaluation of Luminal Patency of a Prototype Large Plastic Biliary Stent in the Palliation of Malignant Distal Biliary Strictures.
Status: Enrolling
Updated:  9/18/2017
Mayo Clinic Rochester
mi
from
Rochester, MN
Patency of a Prototype Large Plastic Biliary Stent in the Palliation of Malignant Distal Biliary Strictures.
Prospective Evaluation of Luminal Patency of a Prototype Large Plastic Biliary Stent in the Palliation of Malignant Distal Biliary Strictures.
Status: Enrolling
Updated: 9/18/2017
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer
Neoadjuvant Androgen Depletion in Combination With Vorinostat Followed by Radical Prostatectomy for Localized Prostate Cancer: Total Androgen-Receptor Gene Expression Targeted Therapy (TARGET)
Status: Enrolling
Updated:  9/18/2017
UCLA Jonsson Comprehensive Cancer Center
mi
from
Los Angeles, CA
Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer
Neoadjuvant Androgen Depletion in Combination With Vorinostat Followed by Radical Prostatectomy for Localized Prostate Cancer: Total Androgen-Receptor Gene Expression Targeted Therapy (TARGET)
Status: Enrolling
Updated: 9/18/2017
UCLA Jonsson Comprehensive Cancer Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer
Neoadjuvant Androgen Depletion in Combination With Vorinostat Followed by Radical Prostatectomy for Localized Prostate Cancer: Total Androgen-Receptor Gene Expression Targeted Therapy (TARGET)
Status: Enrolling
Updated:  9/18/2017
UCSF Medical Center at Parnassus
mi
from
San Francisco, CA
Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer
Neoadjuvant Androgen Depletion in Combination With Vorinostat Followed by Radical Prostatectomy for Localized Prostate Cancer: Total Androgen-Receptor Gene Expression Targeted Therapy (TARGET)
Status: Enrolling
Updated: 9/18/2017
UCSF Medical Center at Parnassus
mi
from
San Francisco, CA
Click here to add this to my saved trials
Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer
Neoadjuvant Androgen Depletion in Combination With Vorinostat Followed by Radical Prostatectomy for Localized Prostate Cancer: Total Androgen-Receptor Gene Expression Targeted Therapy (TARGET)
Status: Enrolling
Updated:  9/18/2017
University of Chicago Comprehensive Cancer Center
mi
from
Chicago, IL
Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer
Neoadjuvant Androgen Depletion in Combination With Vorinostat Followed by Radical Prostatectomy for Localized Prostate Cancer: Total Androgen-Receptor Gene Expression Targeted Therapy (TARGET)
Status: Enrolling
Updated: 9/18/2017
University of Chicago Comprehensive Cancer Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer
Neoadjuvant Androgen Depletion in Combination With Vorinostat Followed by Radical Prostatectomy for Localized Prostate Cancer: Total Androgen-Receptor Gene Expression Targeted Therapy (TARGET)
Status: Enrolling
Updated:  9/18/2017
Johns Hopkins University-Sidney Kimmel Cancer Center
mi
from
Baltimore, MD
Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer
Neoadjuvant Androgen Depletion in Combination With Vorinostat Followed by Radical Prostatectomy for Localized Prostate Cancer: Total Androgen-Receptor Gene Expression Targeted Therapy (TARGET)
Status: Enrolling
Updated: 9/18/2017
Johns Hopkins University-Sidney Kimmel Cancer Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer
Neoadjuvant Androgen Depletion in Combination With Vorinostat Followed by Radical Prostatectomy for Localized Prostate Cancer: Total Androgen-Receptor Gene Expression Targeted Therapy (TARGET)
Status: Enrolling
Updated:  9/18/2017
Dana-Farber Cancer Institute
mi
from
Boston, MA
Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer
Neoadjuvant Androgen Depletion in Combination With Vorinostat Followed by Radical Prostatectomy for Localized Prostate Cancer: Total Androgen-Receptor Gene Expression Targeted Therapy (TARGET)
Status: Enrolling
Updated: 9/18/2017
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer
Neoadjuvant Androgen Depletion in Combination With Vorinostat Followed by Radical Prostatectomy for Localized Prostate Cancer: Total Androgen-Receptor Gene Expression Targeted Therapy (TARGET)
Status: Enrolling
Updated:  9/18/2017
University of Michigan Comprehensive Cancer Center
mi
from
Ann Arbor, MI
Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer
Neoadjuvant Androgen Depletion in Combination With Vorinostat Followed by Radical Prostatectomy for Localized Prostate Cancer: Total Androgen-Receptor Gene Expression Targeted Therapy (TARGET)
Status: Enrolling
Updated: 9/18/2017
University of Michigan Comprehensive Cancer Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer
Neoadjuvant Androgen Depletion in Combination With Vorinostat Followed by Radical Prostatectomy for Localized Prostate Cancer: Total Androgen-Receptor Gene Expression Targeted Therapy (TARGET)
Status: Enrolling
Updated:  9/18/2017
Wayne State University/Karmanos Cancer Institute
mi
from
Detroit, MI
Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer
Neoadjuvant Androgen Depletion in Combination With Vorinostat Followed by Radical Prostatectomy for Localized Prostate Cancer: Total Androgen-Receptor Gene Expression Targeted Therapy (TARGET)
Status: Enrolling
Updated: 9/18/2017
Wayne State University/Karmanos Cancer Institute
mi
from
Detroit, MI
Click here to add this to my saved trials
Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer
Neoadjuvant Androgen Depletion in Combination With Vorinostat Followed by Radical Prostatectomy for Localized Prostate Cancer: Total Androgen-Receptor Gene Expression Targeted Therapy (TARGET)
Status: Enrolling
Updated:  9/18/2017
The Mayo Clinic
mi
from
Rochester, MN
Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer
Neoadjuvant Androgen Depletion in Combination With Vorinostat Followed by Radical Prostatectomy for Localized Prostate Cancer: Total Androgen-Receptor Gene Expression Targeted Therapy (TARGET)
Status: Enrolling
Updated: 9/18/2017
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer
Neoadjuvant Androgen Depletion in Combination With Vorinostat Followed by Radical Prostatectomy for Localized Prostate Cancer: Total Androgen-Receptor Gene Expression Targeted Therapy (TARGET)
Status: Enrolling
Updated:  9/18/2017
UMDNJ-New Jersey Medical School
mi
from
Newark, NJ
Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer
Neoadjuvant Androgen Depletion in Combination With Vorinostat Followed by Radical Prostatectomy for Localized Prostate Cancer: Total Androgen-Receptor Gene Expression Targeted Therapy (TARGET)
Status: Enrolling
Updated: 9/18/2017
UMDNJ-New Jersey Medical School
mi
from
Newark, NJ
Click here to add this to my saved trials
Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer
Neoadjuvant Androgen Depletion in Combination With Vorinostat Followed by Radical Prostatectomy for Localized Prostate Cancer: Total Androgen-Receptor Gene Expression Targeted Therapy (TARGET)
Status: Enrolling
Updated:  9/18/2017
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer
Neoadjuvant Androgen Depletion in Combination With Vorinostat Followed by Radical Prostatectomy for Localized Prostate Cancer: Total Androgen-Receptor Gene Expression Targeted Therapy (TARGET)
Status: Enrolling
Updated: 9/18/2017
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer
Neoadjuvant Androgen Depletion in Combination With Vorinostat Followed by Radical Prostatectomy for Localized Prostate Cancer: Total Androgen-Receptor Gene Expression Targeted Therapy (TARGET)
Status: Enrolling
Updated:  9/18/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer
Neoadjuvant Androgen Depletion in Combination With Vorinostat Followed by Radical Prostatectomy for Localized Prostate Cancer: Total Androgen-Receptor Gene Expression Targeted Therapy (TARGET)
Status: Enrolling
Updated: 9/18/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer
Neoadjuvant Androgen Depletion in Combination With Vorinostat Followed by Radical Prostatectomy for Localized Prostate Cancer: Total Androgen-Receptor Gene Expression Targeted Therapy (TARGET)
Status: Enrolling
Updated:  9/18/2017
Oregon Health and Science University
mi
from
Portland, OR
Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer
Neoadjuvant Androgen Depletion in Combination With Vorinostat Followed by Radical Prostatectomy for Localized Prostate Cancer: Total Androgen-Receptor Gene Expression Targeted Therapy (TARGET)
Status: Enrolling
Updated: 9/18/2017
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer
Neoadjuvant Androgen Depletion in Combination With Vorinostat Followed by Radical Prostatectomy for Localized Prostate Cancer: Total Androgen-Receptor Gene Expression Targeted Therapy (TARGET)
Status: Enrolling
Updated:  9/18/2017
M D Anderson Cancer Center
mi
from
Houston, TX
Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer
Neoadjuvant Androgen Depletion in Combination With Vorinostat Followed by Radical Prostatectomy for Localized Prostate Cancer: Total Androgen-Receptor Gene Expression Targeted Therapy (TARGET)
Status: Enrolling
Updated: 9/18/2017
M D Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer
Neoadjuvant Androgen Depletion in Combination With Vorinostat Followed by Radical Prostatectomy for Localized Prostate Cancer: Total Androgen-Receptor Gene Expression Targeted Therapy (TARGET)
Status: Enrolling
Updated:  9/18/2017
University of Washington Medical Center
mi
from
Seattle, WA
Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer
Neoadjuvant Androgen Depletion in Combination With Vorinostat Followed by Radical Prostatectomy for Localized Prostate Cancer: Total Androgen-Receptor Gene Expression Targeted Therapy (TARGET)
Status: Enrolling
Updated: 9/18/2017
University of Washington Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer
Neoadjuvant Androgen Depletion in Combination With Vorinostat Followed by Radical Prostatectomy for Localized Prostate Cancer: Total Androgen-Receptor Gene Expression Targeted Therapy (TARGET)
Status: Enrolling
Updated:  9/18/2017
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer
Neoadjuvant Androgen Depletion in Combination With Vorinostat Followed by Radical Prostatectomy for Localized Prostate Cancer: Total Androgen-Receptor Gene Expression Targeted Therapy (TARGET)
Status: Enrolling
Updated: 9/18/2017
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Click here to add this to my saved trials
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Status: Enrolling
Updated:  9/18/2017
UPMC Cancer Center - Teramana Cancer Center - Steubenville
mi
from
Steubenville, OH
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Status: Enrolling
Updated: 9/18/2017
UPMC Cancer Center - Teramana Cancer Center - Steubenville
mi
from
Steubenville, OH
Click here to add this to my saved trials
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Status: Enrolling
Updated:  9/18/2017
UPMC Cancer Center - Beaver
mi
from
Beaver, PA
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Status: Enrolling
Updated: 9/18/2017
UPMC Cancer Center - Beaver
mi
from
Beaver, PA
Click here to add this to my saved trials
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Status: Enrolling
Updated:  9/18/2017
UPMC Cancer Center - Clairton
mi
from
Clairton, PA
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Status: Enrolling
Updated: 9/18/2017
UPMC Cancer Center - Clairton
mi
from
Clairton, PA
Click here to add this to my saved trials
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Status: Enrolling
Updated:  9/18/2017
UPMC Cancer Center - Arnold Palmer Pavilion - Greensburg
mi
from
Greensburg, PA
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Status: Enrolling
Updated: 9/18/2017
UPMC Cancer Center - Arnold Palmer Pavilion - Greensburg
mi
from
Greensburg, PA
Click here to add this to my saved trials
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Status: Enrolling
Updated:  9/18/2017
UPMC Cancer Center - Oakbrook Commons - Greensburg
mi
from
Greensburg, PA
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Status: Enrolling
Updated: 9/18/2017
UPMC Cancer Center - Oakbrook Commons - Greensburg
mi
from
Greensburg, PA
Click here to add this to my saved trials
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Status: Enrolling
Updated:  9/18/2017
UPMC Cancer Center - Indiana
mi
from
Indiana, PA
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Status: Enrolling
Updated: 9/18/2017
UPMC Cancer Center - Indiana
mi
from
Indiana, PA
Click here to add this to my saved trials
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Status: Enrolling
Updated:  9/18/2017
UPMC Cancer Center - John P. Murtha Pavilion - Johnstown
mi
from
Johnstown, PA
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Status: Enrolling
Updated: 9/18/2017
UPMC Cancer Center - John P. Murtha Pavilion - Johnstown
mi
from
Johnstown, PA
Click here to add this to my saved trials
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Status: Enrolling
Updated:  9/18/2017
UPMC Cancer Center - McKeesport
mi
from
McKeesport, PA
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Status: Enrolling
Updated: 9/18/2017
UPMC Cancer Center - McKeesport
mi
from
McKeesport, PA
Click here to add this to my saved trials
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Status: Enrolling
Updated:  9/18/2017
UPMC Cancer Center - Monroeville
mi
from
Monroeville, PA
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Status: Enrolling
Updated: 9/18/2017
UPMC Cancer Center - Monroeville
mi
from
Monroeville, PA
Click here to add this to my saved trials
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Status: Enrolling
Updated:  9/18/2017
UPMC Cancer Center - Sewickley Medical Oncology/Hematology Group
mi
from
Moon, PA
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Status: Enrolling
Updated: 9/18/2017
UPMC Cancer Center - Sewickley Medical Oncology/Hematology Group
mi
from
Moon, PA
Click here to add this to my saved trials
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Status: Enrolling
Updated:  9/18/2017
UPMC Cancer Center - New Castle
mi
from
New Castle, PA
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Status: Enrolling
Updated: 9/18/2017
UPMC Cancer Center - New Castle
mi
from
New Castle, PA
Click here to add this to my saved trials
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Status: Enrolling
Updated:  9/18/2017
UPMC Cancer Center - St. Margaret's
mi
from
Pittsburgh, PA
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Status: Enrolling
Updated: 9/18/2017
UPMC Cancer Center - St. Margaret's
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Status: Enrolling
Updated:  9/18/2017
UPMC Cancer Center - Mercy
mi
from
Pittsburgh, PA
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Status: Enrolling
Updated: 9/18/2017
UPMC Cancer Center - Mercy
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Status: Enrolling
Updated:  9/18/2017
University of Pittsburgh Cancer Institute / Hillman Cancer Center
mi
from
Pittsburgh, PA
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Status: Enrolling
Updated: 9/18/2017
University of Pittsburgh Cancer Institute / Hillman Cancer Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Status: Enrolling
Updated:  9/18/2017
UPMC Cancer Center - Passavant
mi
from
Pittsburgh, PA
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Status: Enrolling
Updated: 9/18/2017
UPMC Cancer Center - Passavant
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Status: Enrolling
Updated:  9/18/2017
UPMC Cancer Center - Upper St. Clair
mi
from
Pittsburgh, PA
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Status: Enrolling
Updated: 9/18/2017
UPMC Cancer Center - Upper St. Clair
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Status: Enrolling
Updated:  9/18/2017
UPMC Cancer Center - Uniontown
mi
from
Uniontown, PA
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Status: Enrolling
Updated: 9/18/2017
UPMC Cancer Center - Uniontown
mi
from
Uniontown, PA
Click here to add this to my saved trials
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Status: Enrolling
Updated:  9/18/2017
UPMC Cancer Center - Washington
mi
from
Washington, PA
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Status: Enrolling
Updated: 9/18/2017
UPMC Cancer Center - Washington
mi
from
Washington, PA
Click here to add this to my saved trials
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Status: Enrolling
Updated:  9/18/2017
UPMC Cancer Center - North Hills
mi
from
Wexford, PA
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Status: Enrolling
Updated: 9/18/2017
UPMC Cancer Center - North Hills
mi
from
Wexford, PA
Click here to add this to my saved trials
Internal Radiation Therapy in Treating Patients With Prostate Cancer
A Pilot Study of High Dose Rate Brachytherapy as Definitive Management for Intermediate Risk Prostate Cancer
Status: Enrolling
Updated:  9/19/2017
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Internal Radiation Therapy in Treating Patients With Prostate Cancer
A Pilot Study of High Dose Rate Brachytherapy as Definitive Management for Intermediate Risk Prostate Cancer
Status: Enrolling
Updated: 9/19/2017
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Clinical Trial of Standard Versus Goal-Directed Perioperative Fluid Management (GDT) for Patients Undergoing Liver Resection
A Prospective Randomized Controlled Clinical Trial of Standard Compared to Goal-directed Perioperative Fluid Management (GDT) for Patients Undergoing Liver Resection
Status: Enrolling
Updated:  9/19/2017
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Clinical Trial of Standard Versus Goal-Directed Perioperative Fluid Management (GDT) for Patients Undergoing Liver Resection
A Prospective Randomized Controlled Clinical Trial of Standard Compared to Goal-directed Perioperative Fluid Management (GDT) for Patients Undergoing Liver Resection
Status: Enrolling
Updated: 9/19/2017
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Phase I Study of KRN330 Monoclonal Antibody in Patients With Colorectal Cancer
Phase I Study of KRN330 Monoclonal Antibody in Patients With Colorectal Cancer
Status: Enrolling
Updated:  9/19/2017
Sarah Cannon Research Institute
mi
from
Nashville, TN
Phase I Study of KRN330 Monoclonal Antibody in Patients With Colorectal Cancer
Phase I Study of KRN330 Monoclonal Antibody in Patients With Colorectal Cancer
Status: Enrolling
Updated: 9/19/2017
Sarah Cannon Research Institute
mi
from
Nashville, TN
Click here to add this to my saved trials
Phase I Study of KRN330 Monoclonal Antibody in Patients With Colorectal Cancer
Phase I Study of KRN330 Monoclonal Antibody in Patients With Colorectal Cancer
Status: Enrolling
Updated:  9/19/2017
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Phase I Study of KRN330 Monoclonal Antibody in Patients With Colorectal Cancer
Phase I Study of KRN330 Monoclonal Antibody in Patients With Colorectal Cancer
Status: Enrolling
Updated: 9/19/2017
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Treatment Plan for an Individual Patient With Recurrent Uterine Papillary Serous Carcinoma (UPSC) With PIK3CA Gene Mutation
CRAD001X2401: Treatment Plan for an Individual Patient With Recurrent Uterine Papillary Serous Carcinoma (UPSC) With PIK3CA Gene Mutation
Status: Enrolling
Updated:  9/19/2017
Greater Baltimore Medical Center
mi
from
Baltimore, MD
Treatment Plan for an Individual Patient With Recurrent Uterine Papillary Serous Carcinoma (UPSC) With PIK3CA Gene Mutation
CRAD001X2401: Treatment Plan for an Individual Patient With Recurrent Uterine Papillary Serous Carcinoma (UPSC) With PIK3CA Gene Mutation
Status: Enrolling
Updated: 9/19/2017
Greater Baltimore Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer
This Protocol is a Randomized Prospective Study Comparing Prophylactic and on Demand Sildenafil Citrate Usage Administered During and After Radiotherapy With or Without Hormone Therapy Versus Radiotherapy With or Without Hormone Therapy Alone for the Preservation of Erectile Function After Therapy for Potent Patients With Clinically Localized Prostate Cancer
Status: Enrolling
Updated:  9/19/2017
Memorial Sloan-Kettering Cancer Center - Basking Ridge
mi
from
Basking Ridge, NJ
Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer
This Protocol is a Randomized Prospective Study Comparing Prophylactic and on Demand Sildenafil Citrate Usage Administered During and After Radiotherapy With or Without Hormone Therapy Versus Radiotherapy With or Without Hormone Therapy Alone for the Preservation of Erectile Function After Therapy for Potent Patients With Clinically Localized Prostate Cancer
Status: Enrolling
Updated: 9/19/2017
Memorial Sloan-Kettering Cancer Center - Basking Ridge
mi
from
Basking Ridge, NJ
Click here to add this to my saved trials
Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer
This Protocol is a Randomized Prospective Study Comparing Prophylactic and on Demand Sildenafil Citrate Usage Administered During and After Radiotherapy With or Without Hormone Therapy Versus Radiotherapy With or Without Hormone Therapy Alone for the Preservation of Erectile Function After Therapy for Potent Patients With Clinically Localized Prostate Cancer
Status: Enrolling
Updated:  9/19/2017
Memorial Sloan-Kettering Cancer Center at Commack
mi
from
Commack, NY
Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer
This Protocol is a Randomized Prospective Study Comparing Prophylactic and on Demand Sildenafil Citrate Usage Administered During and After Radiotherapy With or Without Hormone Therapy Versus Radiotherapy With or Without Hormone Therapy Alone for the Preservation of Erectile Function After Therapy for Potent Patients With Clinically Localized Prostate Cancer
Status: Enrolling
Updated: 9/19/2017
Memorial Sloan-Kettering Cancer Center at Commack
mi
from
Commack, NY
Click here to add this to my saved trials
Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer
This Protocol is a Randomized Prospective Study Comparing Prophylactic and on Demand Sildenafil Citrate Usage Administered During and After Radiotherapy With or Without Hormone Therapy Versus Radiotherapy With or Without Hormone Therapy Alone for the Preservation of Erectile Function After Therapy for Potent Patients With Clinically Localized Prostate Cancer
Status: Enrolling
Updated:  9/19/2017
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer
This Protocol is a Randomized Prospective Study Comparing Prophylactic and on Demand Sildenafil Citrate Usage Administered During and After Radiotherapy With or Without Hormone Therapy Versus Radiotherapy With or Without Hormone Therapy Alone for the Preservation of Erectile Function After Therapy for Potent Patients With Clinically Localized Prostate Cancer
Status: Enrolling
Updated: 9/19/2017
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer
This Protocol is a Randomized Prospective Study Comparing Prophylactic and on Demand Sildenafil Citrate Usage Administered During and After Radiotherapy With or Without Hormone Therapy Versus Radiotherapy With or Without Hormone Therapy Alone for the Preservation of Erectile Function After Therapy for Potent Patients With Clinically Localized Prostate Cancer
Status: Enrolling
Updated:  9/19/2017
Memorial Sloan Kettering Cancer Center at Mercy Medical Center
mi
from
Rockville Centre, NY
Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer
This Protocol is a Randomized Prospective Study Comparing Prophylactic and on Demand Sildenafil Citrate Usage Administered During and After Radiotherapy With or Without Hormone Therapy Versus Radiotherapy With or Without Hormone Therapy Alone for the Preservation of Erectile Function After Therapy for Potent Patients With Clinically Localized Prostate Cancer
Status: Enrolling
Updated: 9/19/2017
Memorial Sloan Kettering Cancer Center at Mercy Medical Center
mi
from
Rockville Centre, NY
Click here to add this to my saved trials
Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer
This Protocol is a Randomized Prospective Study Comparing Prophylactic and on Demand Sildenafil Citrate Usage Administered During and After Radiotherapy With or Without Hormone Therapy Versus Radiotherapy With or Without Hormone Therapy Alone for the Preservation of Erectile Function After Therapy for Potent Patients With Clinically Localized Prostate Cancer
Status: Enrolling
Updated:  9/19/2017
Memorial Sloan-Kettering Cancer Center at Phelps Memorial Hospital Center
mi
from
Sleepy Hollow, NY
Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer
This Protocol is a Randomized Prospective Study Comparing Prophylactic and on Demand Sildenafil Citrate Usage Administered During and After Radiotherapy With or Without Hormone Therapy Versus Radiotherapy With or Without Hormone Therapy Alone for the Preservation of Erectile Function After Therapy for Potent Patients With Clinically Localized Prostate Cancer
Status: Enrolling
Updated: 9/19/2017
Memorial Sloan-Kettering Cancer Center at Phelps Memorial Hospital Center
mi
from
Sleepy Hollow, NY
Click here to add this to my saved trials
A Phase II Trial of Cetuximab and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer
A Phase II Trial of Cetuximab and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer
Status: Enrolling
Updated:  9/19/2017
University of Michigan
mi
from
Ann Arbor, MI
A Phase II Trial of Cetuximab and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer
A Phase II Trial of Cetuximab and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer
Status: Enrolling
Updated: 9/19/2017
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials